See more : Credit Suisse Group AG (CS) Income Statement Analysis – Financial Results
Complete financial analysis of DaVita Inc. (DVA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DaVita Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Sriracha Construction Public Company Limited (SRICHA.BK) Income Statement Analysis – Financial Results
- CPI Aerostructures, Inc. (CVU) Income Statement Analysis – Financial Results
- Excelsior Medical Co., Ltd. (4104.TW) Income Statement Analysis – Financial Results
- Gaming Innovation Group Inc. (GIGSEK.ST) Income Statement Analysis – Financial Results
- Allied Healthcare Products, Inc. (AHPIQ) Income Statement Analysis – Financial Results
DaVita Inc. (DVA)
About DaVita Inc.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.14B | 11.61B | 11.62B | 11.55B | 11.39B | 11.40B | 10.88B | 14.75B | 13.78B | 12.80B | 11.76B | 8.19B | 6.79B | 6.45B | 6.11B | 5.66B | 5.26B | 4.88B | 2.97B | 2.30B | 2.05B | 1.85B | 1.65B | 1.49B | 1.45B | 1.20B | 438.20M | 272.90M | 89.70M | 99.00M |
| Cost of Revenue | 8.32B | 8.21B | 7.97B | 7.99B | 7.91B | 8.20B | 7.64B | 10.65B | 9.82B | 9.12B | 8.20B | 5.58B | 4.68B | 4.47B | 4.25B | 3.92B | 3.59B | 3.39B | 2.04B | 1.56B | 1.36B | 1.22B | 1.10B | 1.03B | 993.24M | 772.70M | 292.50M | 184.00M | 57.40M | 65.60M |
| Gross Profit | 3.82B | 3.40B | 3.65B | 3.56B | 3.47B | 3.21B | 3.24B | 4.10B | 3.96B | 3.68B | 3.57B | 2.61B | 2.11B | 1.97B | 1.86B | 1.74B | 1.67B | 1.49B | 938.68M | 743.53M | 685.86M | 636.95M | 550.10M | 454.15M | 452.11M | 432.20M | 145.70M | 88.90M | 32.30M | 33.40M |
| Gross Profit Ratio | 31.47% | 29.29% | 31.38% | 30.84% | 30.50% | 28.14% | 29.76% | 27.79% | 28.71% | 28.73% | 30.31% | 31.85% | 31.08% | 30.60% | 30.45% | 30.74% | 31.80% | 30.54% | 31.56% | 32.35% | 33.52% | 34.34% | 33.32% | 30.56% | 31.28% | 35.87% | 33.25% | 32.58% | 36.01% | 33.74% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.47B | 1.36B | 1.20B | 1.25B | 1.10B | 1.14B | 1.06B | 1.59B | 1.45B | 1.26B | 1.18B | 894.58M | 691.24M | 579.00M | 531.53M | 654.47M | 627.92M | 579.72M | 334.38M | 233.04M | 195.33M | 181.33M | 126.90M | 163.27M | 263.81M | 120.20M | 38.70M | 24.80M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.47B | 1.36B | 1.20B | 1.25B | 1.10B | 1.14B | 1.06B | 1.59B | 1.45B | 1.26B | 1.18B | 894.58M | 691.24M | 579.00M | 531.53M | 654.47M | 627.92M | 579.72M | 334.38M | 233.04M | 195.33M | 181.33M | 126.90M | 163.27M | 263.81M | 120.20M | 38.70M | 24.80M | 9.40M | 11.50M |
| Other Expenses | 743.66M | 732.60M | 680.62M | 630.44M | 615.15M | 583.74M | 17.67M | 8.73M | 8.89M | 2.37M | 4.79M | 3.74M | 455.42M | 396.63M | 388.33M | 263.45M | 183.68M | 171.16M | 138.93M | 100.36M | 112.00M | 64.29M | 105.21M | 111.61M | 112.48M | 92.00M | 27.10M | 15.40M | 4.40M | 0.00 |
| Operating Expenses | 2.22B | 2.09B | 1.88B | 1.88B | 1.72B | 1.72B | 1.62B | 2.32B | 2.59B | 1.88B | 2.11B | 1.33B | 956.43M | 975.63M | 919.86M | 917.92M | 811.60M | 750.88M | 473.30M | 333.40M | 307.33M | 245.62M | 232.11M | 274.88M | 376.29M | 212.20M | 65.80M | 40.20M | 13.80M | 16.20M |
| Cost & Expenses | 10.54B | 10.30B | 9.85B | 9.87B | 9.63B | 9.91B | 9.26B | 12.97B | 12.42B | 11.00B | 10.31B | 6.91B | 5.64B | 5.45B | 5.17B | 4.84B | 4.40B | 4.14B | 2.51B | 1.89B | 1.67B | 1.46B | 1.33B | 1.31B | 1.37B | 984.90M | 358.30M | 224.20M | 71.20M | 81.80M |
| Interest Income | 0.00 | 368.75M | 279.75M | 297.03M | 435.23M | 0.00 | 0.00 | 0.00 | 0.00 | 17.41M | 0.00 | 288.53M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 398.55M | 357.02M | 285.25M | 304.11M | 443.82M | 487.44M | 430.63M | 414.38M | 405.94M | 410.29M | 429.94M | 0.00 | 241.09M | 255.99M | 185.76M | 199.89M | 156.95M | 489.02M | 107.74M | 44.07M | 113.71M | 98.33M | 71.43M | 149.58M | 399.35M | 256.00M | 15.40M | 14.40M | 4.10M | 0.00 |
| Depreciation & Amortization | 745.44M | 732.60M | 680.62M | 630.44M | 615.15M | 591.04M | 559.91M | 509.50M | 638.02M | 590.94M | 528.12M | 343.91M | 267.32M | 234.38M | 228.99M | 216.92M | 193.47M | 173.30M | 119.72M | 86.67M | 74.69M | 64.67M | 105.21M | 111.61M | 112.48M | 92.00M | 27.10M | 15.40M | 4.40M | 4.70M |
| EBITDA | 2.35B | 2.05B | 2.45B | 2.31B | 2.37B | 2.08B | 2.38B | 2.55B | 1.77B | 2.43B | 2.10B | 1.63B | 1.43B | 1.23B | 1.16B | 1.03B | 1.06B | 912.73M | 465.37M | 467.79M | 434.62M | 448.49M | 416.07M | 290.88M | 188.30M | 303.40M | 165.20M | 105.70M | 33.20M | 21.90M |
| EBITDA Ratio | 19.33% | 17.71% | 21.38% | 20.42% | 21.19% | 18.30% | 22.12% | 17.06% | 14.37% | 18.06% | 17.23% | 19.96% | 20.94% | 19.10% | 19.14% | 18.13% | 18.58% | 23.33% | 19.50% | 21.43% | 23.29% | 24.25% | 25.36% | 20.36% | 22.83% | 31.98% | 23.87% | 22.79% | 24.75% | 22.12% |
| Operating Income | 1.60B | 1.34B | 1.80B | 1.69B | 1.64B | 1.53B | 1.81B | 1.89B | 1.17B | 1.82B | 1.55B | 1.30B | 1.13B | 997.03M | 940.27M | 821.77M | 862.21M | 739.43M | 465.37M | 410.12M | 378.54M | 391.33M | 317.99M | 179.27M | 75.82M | 220.00M | 79.90M | 48.70M | 18.50M | 17.20M |
| Operating Income Ratio | 13.20% | 11.53% | 15.47% | 14.67% | 14.43% | 13.38% | 16.67% | 12.85% | 8.49% | 14.19% | 13.18% | 15.84% | 16.65% | 15.46% | 15.39% | 14.52% | 16.38% | 15.15% | 15.65% | 17.84% | 18.50% | 21.10% | 19.26% | 12.06% | 5.25% | 18.26% | 18.23% | 17.85% | 20.62% | 17.37% |
| Total Other Income/Expenses | -425.69M | -372.78M | -278.88M | -376.37M | -447.88M | -477.35M | -412.97M | -406.61M | -413.63M | -505.47M | -425.16M | -295.78M | -238.11M | -252.57M | -182.05M | -164.97M | -234.69M | -263.67M | -134.27M | -19.24M | -71.67M | -67.64M | -68.29M | -134.34M | -257.65M | -164.40M | 1.30M | 8.70M | -3.60M | -8.80M |
| Income Before Tax | 1.18B | 966.28M | 1.52B | 1.32B | 1.20B | 1.05B | 1.40B | 1.49B | 723.14M | 1.31B | 1.12B | 1.00B | 892.67M | 744.46M | 758.22M | 609.46M | 627.52M | 475.76M | 331.10M | 361.88M | 288.27M | 316.19M | 240.94M | 44.94M | -181.83M | 56.90M | 62.10M | 40.10M | 11.10M | 8.40M |
| Income Before Tax Ratio | 9.70% | 8.32% | 13.07% | 11.41% | 10.50% | 9.19% | 12.87% | 10.10% | 5.25% | 10.24% | 9.56% | 12.23% | 13.14% | 11.55% | 12.41% | 10.77% | 11.92% | 9.75% | 11.13% | 15.74% | 14.09% | 17.05% | 14.60% | 3.02% | -12.58% | 4.72% | 14.17% | 14.69% | 12.37% | 8.48% |
| Income Tax Expense | 220.12M | 198.09M | 306.73M | 313.93M | 279.63M | 258.40M | 323.86M | 455.81M | 295.73M | 446.34M | 381.01M | 359.85M | 315.74M | 260.24M | 278.47M | 235.30M | 245.74M | 186.43M | 123.68M | 139.63M | 112.48M | 129.50M | 104.60M | 27.96M | -34.57M | 41.60M | 25.10M | 16.40M | 4.60M | 3.50M |
| Net Income | 691.54M | 768.19M | 978.45M | 773.64M | 810.98M | 790.08M | 663.62M | 879.87M | 269.73M | 723.11M | 633.45M | 536.02M | 478.00M | 405.68M | 422.68M | 374.16M | 381.78M | 289.69M | 228.64M | 222.25M | 175.79M | 157.33M | 137.32M | 13.49M | -147.26M | -4.30M | 37.00M | 16.00M | 9.10M | 4.90M |
| Net Income Ratio | 5.70% | 6.62% | 8.42% | 6.70% | 7.12% | 6.93% | 6.10% | 5.97% | 1.96% | 5.65% | 5.38% | 6.55% | 7.04% | 6.29% | 6.92% | 6.61% | 7.25% | 5.94% | 7.69% | 9.67% | 8.59% | 8.48% | 8.32% | 0.91% | -10.19% | -0.36% | 8.44% | 5.86% | 10.14% | 4.95% |
| EPS | 7.62 | 8.26 | 9.30 | 6.54 | 5.29 | 4.63 | 3.52 | 4.36 | 1.27 | 3.41 | 3.02 | 2.79 | 2.52 | 2.00 | 2.04 | 1.78 | 1.80 | 1.40 | 1.13 | 1.13 | 0.93 | 0.73 | 0.55 | 0.06 | -0.60 | -0.02 | 0.24 | 0.14 | 0.08 | 0.09 |
| EPS Diluted | 7.42 | 8.02 | 8.90 | 6.39 | 5.27 | 4.58 | 3.47 | 4.29 | 1.25 | 3.33 | 2.95 | 2.74 | 2.48 | 1.97 | 2.03 | 1.77 | 1.78 | 1.37 | 1.10 | 1.08 | 0.77 | 0.58 | 0.49 | 0.05 | -0.60 | -0.02 | 0.24 | 0.13 | 0.08 | 0.08 |
| Weighted Avg Shares Out | 90.79M | 92.99M | 105.23M | 119.80M | 153.18M | 170.79M | 188.63M | 201.64M | 211.87M | 212.30M | 209.94M | 192.04M | 189.32M | 203.01M | 207.21M | 210.30M | 211.79M | 207.04M | 201.52M | 197.45M | 188.69M | 215.49M | 251.30M | 244.74M | 243.46M | 240.43M | 155.05M | 114.73M | 111.48M | 54.42M |
| Weighted Avg Shares Out (Dil) | 93.18M | 95.83M | 109.95M | 122.62M | 153.81M | 172.36M | 191.35M | 204.90M | 216.25M | 216.93M | 214.76M | 195.94M | 193.06M | 206.12M | 208.34M | 211.88M | 214.84M | 211.59M | 208.14M | 205.72M | 227.52M | 271.44M | 278.82M | 249.47M | 243.46M | 245.10M | 155.05M | 119.94M | 111.48M | 61.22M |
The Final Peak Week Of The Q2 Season Begins Amid Souring Economic Data
This marks the last peak week of the Q2 earnings season with 3,908 companies expected to report. Earnings have come in better-than-expected, but tend to be overshadowed by economic data. Outlier earnings this week include: CSX, CAT, and VFC.
Strength in Kidney Care Likely to Aid DaVita's (DVA) Q2 Earnings
Improvement in RPT and cost-saving initiatives are likely to have boosted DaVita's (DVA) top line in the second quarter.
4 Stocks to Watch From a Challenging Outpatient Home Health Industry
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, EHC and ADUS are well-poised to gain.
DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights
In the latest trading session, DaVita HealthCare (DVA) closed at $136.47, marking a -1.93% move from the previous day.
2 Warren Buffett small-cap stocks to turn $100 into $1000 by 2025
As the second half of 2024 unfolds, the stock market continues to offer various investment opportunities ranging from large to small-cap equities.
DaVita HealthCare (DVA) Laps the Stock Market: Here's Why
The latest trading day saw DaVita HealthCare (DVA) settling at $139.96, representing a +1.46% change from its previous close.
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call
DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 6, 2024, at 5:00 p.m. Eastern Time.
DaVita HealthCare (DVA) Rises Higher Than Market: Key Facts
DaVita HealthCare (DVA) reachead $137.72 at the closing of the latest trading day, reflecting a +1.3% change compared to its last close.
DaVita (DVA) Gains 29.8% YTD: What's Driving the Stock?
DaVita's (DVA) shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.
Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits Research
Renal Denervation Devices Market Size, Share & Trends Analysis Report By Technology (Radiofrequency-based, Ultrasound-based, Micro-infusion-based, Others), By End User (Hospitals & Clinics, Ambulatory surgery centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032...
Source: https://incomestatements.info
Category: Stock Reports